RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer. The U.S. Food and Drug Administration (FDA) approved Genentechâs Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC).
A new cancer drug, Opdivo, is working so well that pharmaceutical giant Bristol-Myers Squibb announced Monday it is stopping a trial in lung cancer two years ahead of schedule. The trial compared Opdivo to Docetaxel, a type of chemo used for patients whose cancers have recurred after treatment. The study, in 234 patients, was the largest trial of the drug in lung cancer.